NEW YORK, January 4, 2026, 19:53 ET — Market closed
- Thermo Fisher shares finished Friday up about 2.3% at $592.51, after trading between $579 and $594.
- The next company catalyst is its fourth-quarter and full-year 2025 results, due before the open on Jan. 29. Thermo Fisher Scientific
- Macro focus before then includes the U.S. employment report due Jan. 9, a key input for rate expectations. Bureau of Labor Statistics
Thermo Fisher Scientific Inc shares closed Friday up about 2.3% at $592.51, beating the broader market’s modest advance in the first session of 2026. Reuters
The move matters heading into Monday because investors are rotating from thin holiday trade into a January calendar packed with economic data and the start of earnings season. Thermo Fisher’s results later this month will be one of the first big readouts for life-science tools demand. Thermo Fisher Scientific
Thermo Fisher is a bellwether for “life science tools” — lab instruments, consumables and services used by drugmakers and research labs. Its outlook can shape sentiment for peers such as Danaher, which also rose on Friday. MarketWatch
On Friday, Thermo Fisher traded between $579 and $594 and finished near the top of that range, a setup traders will watch as near-term support and resistance into Monday’s open. About 2.0 million shares changed hands.
With U.S. equities still priced for solid profit growth, investors have little patience for earnings stumbles early in the year. “Good/very good earnings growth and continued investor confidence” are part of the 2026 checklist, Nicholas Colas, co-founder of DataTrek Research, wrote in a note. Investing
For Thermo Fisher, the next hard catalyst is Jan. 29, when the company said it will release fourth-quarter and full-year 2025 results before the market opens and hold a conference call at 8:30 a.m. ET. Thermo Fisher Scientific
Investors will look for updates on customer spending in pharma and biotech, where budgets can swing with funding conditions, and on whether service demand is improving as drugmakers prioritize pipeline programs. They will also watch margin commentary, a key driver for large-cap healthcare tools. Thermo Fisher Scientific
The macro “tell” before Thermo Fisher reports is Friday’s U.S. employment report. The Bureau of Labor Statistics has scheduled the December Employment Situation release for Jan. 9 at 8:30 a.m. ET, a data point that can shift rate expectations and, by extension, equity valuations. Bureau of Labor Statistics
A risk for Thermo Fisher bulls is that a weaker-than-expected jobs print or a cautious company outlook reignites worries about 2026 growth, especially if customers delay purchases of big-ticket instruments. A break back toward Friday’s $579 session low would signal that the early-January bid is fading. Bureau of Labor Statistics
Markets reopen Monday, but the next scheduled catalysts on the calendar are the Jan. 9 U.S. jobs report and Thermo Fisher’s Jan. 29 earnings release and call. Bureau of Labor Statistics
